Oregon Wins Temporary Supreme Court Reprieve as Abortion Pill Stays Available by Mail
Reacting swiftly to the ruling by the Fifth Circuit Court of Appeals to ban the distribution by mail of an abortion pill has ended successfully for Oregon, with the Supreme Court yesterday staying the ruling until Monday, May 11.
Women Can Continue to Use Mifepristone Until May 11 Ruling
Women throughout the country can continue to obtain the abortion medication until May 11, while the Supreme Court considers a stay application by the manufacturers.
Sources: Oregon Department of Justice, Supreme Court filings and FDA mifepristone materials
Dailytidings.com
Oregon Attorney General Dan Rayfield and a coalition of 21 states and the District of Columbia applied to the Supreme Court to overturn the ruling, which restricts access to the abortion pill, Mifepristone.
“Mifepristone is a safe, FDA-approved drug, and has been used by millions of people across our country for decades,” said Rayfield in a press statement.
Coalition Argued That Ruling Was Not Scientific or Legal
Rayfield and the coalition argued in an amicus brief filed with the Supreme Court that the ruling by the Fifth Circuit Court of Appeals was not scientifically or legally supported.
Furthermore, it would create chaos nationwide, interfering with states’ ability to protect reproductive healthcare access. The coalition argued that rural and low-income areas would be particularly hard-hit by the ruling.
Mifepristone is administered in combination with Misoprostol, a standard medication to terminate pregnancies through 11 weeks.
Studies Revealed the Abortion Pill Safe to Use Without Direct Supervision
Initially, the FDA ruled that only physicians could prescribe the pill at in-person appointments. However, the requirements were stopped in 2023 after the FDA reviewed studies involving thousands of pregnancies that indicated the abortion medication was safe to use without direct supervision.
The FDA decision enabled patients to obtain Mifepristone through certified mail-order pharmacies, and other approved channels. This expanded access to abortions for patients in outlying districts.
Tele-medicine escalated access to abortions in Oregon from 5% in 2022 to 27% by 2025. Today, abortion by medication accounts for 63% of all procedures in the U.S. healthcare system, and tele-health accounts for one-in-four abortions.